¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03
±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ º´Çà  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 042-484-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:00~10:20 Current status of aHUS in Korea  ¾È¼­¿¬(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:20~10:45 Differential diagnosis of thrombotic microangiopathy  °í¿µÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:45~11:10 Optimal use of eculizumab in the treatment of aHUS in Korea  ±èÁø¼®(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:10~11:30 Panel discussion  ¹®¿µÃ¶ÀåÁØÈ£(ÀÌÈ­ÀǴ뼺±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:30~13:00 Lunch ¹× Oral presentation  ¹æ¼ö¹Ì À̽ÂÈñ ±è¼öÁ¾(¼­¿ïÀÇ´ë ±¹¸³º¸°Ç¿¬±¸¿ø ÃæºÏ´ë ÀÇÇаú) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:00~13:25 Update of Optimal Antithrombotic Therapy after TAVR  ¹ÎÇʱâ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:25~13:50 Cutting Edge on Optimal Therapy for Pulmonary Embolism  È²Çå±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:50~14:15 Present and Future of Aspirin as Primary Prevention of ASCVD  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 14:15~14:30 Panel discussion  Çã¾Ö¿µ½ÉµÎ¼±(°­¿øÀÇ´ëÀü³²ÀÇ´ë) 
È޽Ġ09-03  14:30~15:00 Coffee Break  () 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:00~15:25 Management of Antithrombotic Agents for Patients undergoing Procedure/Operation  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:25~15:50 Cardiovascular Oncology: Optimal Antithrombotic Therapy in Cancer Patients  Á¶ÀÎÁ¤(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:50~16:15 Antithrombotic therapy for acute stage and secondary prevention of stroke  À̵¿È¯(À»ÁöÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 16:15~16:30 Panel discussion  ½Åµ¿È£°­¹Î°æ(¿¬¼¼ÀÇ´ëÇѸ²ÀÇ´ë) 
±âŸ 09-03  16:30~17:00 ¿ì¼ö¿¬Á¦»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦77Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2021) 3ÀÏÂ÷ : 2021-09-03
´ÙÀ½±Û Çѱ¹ÀÇÇб³À°ÇÐȸ (¿Â¶óÀÎ) 2021³âµµ ÇϹݱ⠽ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2021-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
420 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦1ȸ ºñ¸¸Àü¹®°¡ ½ÉÈ­°úÁ¤: ºñ¸¸ Àü¹® ÀÎÁ¤ÀÇ ±³À° Part 1. : 2018-09-09 0 582 2018-08-15
419 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 2018³â Çù·Âº´ÀÇ¿ø ÀÇ»ç ¿¬¼ö°­Á : 2018-09-09 0 1,364 2018-08-15
418 ¼­¿ï Á¦1ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ESD¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 868 2018-08-15
417 ¼­¿ï Á¦11ȸ ¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ÁßȯÀÚÀÇÇÐ ¿¬¼ö°­Á Basic Concepts in Intensive Care, 2018 (BACIC 2018) : 2018-09-08 0 1,382 2018-08-15
416 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °í·Á´ëÇб³ °í°üÀý ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,106 2018-08-15
415 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-08 0 518 2018-08-15
414 ºÎ»ê ´ëÇѼ¼Æ÷º´¸®ÇÐȸ International Session of the 30th Annual Fall Meeting of the Korean Society for Cytopathology : 2018-09-08 0 599 2018-08-15
413 ºÎ»ê 2018³â ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2018-09-08 0 1,042 2018-08-15
412 ±¤ÁÖ Àü³²´ëº´¿ø Á¦ 3Â÷ Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç ¿¬¼ö°­Á : 2018-09-08 0 1,091 2018-08-15
411 ºÎ»ê ºÎ»ê´ëº´¿ø 2018³â Á¦1Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-09-08 0 1,434 2018-08-15
410 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¦6ȸ ¾ÆÁÖ ´ç´¢¹ß ¹× â»ó ½ÉÆ÷Áö¾ö : 2018-09-08 0 1,214 2018-08-15
409 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ÁßȯÀÚÀÇÇнÉÆ÷Áö¿ò ¹× ±â°èȯ±â¿öÅ©¼ó : 2018-09-08 0 739 2018-08-15
408 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-07 0 467 2018-08-15
407 ´ëÀü Ãæ³²´ëÇб³º´¿ø KMDS 2018³â °¡À»Áý´ãȸ : 2018-09-07 0 401 2018-08-15
406 °æ±â 2018³âµµ ¼º³²½Ã ¾È°úÀÇ»çȸ ½ÉÆ÷Áö¾ö : 2018-09-07 0 996 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷